Ibuprofen Versus Ketorolac For Postoperative Pain Relief After Cesarean Section

NCT05907993 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-02-28

No results posted yet for this study

Summary

The aim of this study will be to evaluate the effectiveness of intravenous ibuprofen versus intravenous ketorolac for postoperative pain relief after caesarian section

1. The Primary outcome is measurement of visual analogue score during rest and movement
2. The Secondary outcome is measurement of 24 hours opioids requirements.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Ibuprofen 800 mg

Intravenous Ibuprofen versus intravenous Ketorolac for postoperative pain relief

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Ahmed S. Shehab, MD · Alexandria University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-09-30
Completion
2023-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05907993 on ClinicalTrials.gov